Square 1 Bank is a full-service commercial bank that provides financial services to entrepreneurs and venture capitalists.
Business Model:
Revenue: $10M
Employees: 2-10
Square 1 Bank was acquired by
PacWest Bancorp.
The acquisition happend on 2015-03-02.
Details of the transaction were not public
Address: 406 Blackwell St Ste 240
City: Durham
State: NC
Zip: 27701
Country: US
Square 1 Bank is a full service commercial bank dedicated exclusively to serving the financial needs of the venture capital community and entrepreneurs in all stages of growth and expansion. Square 1&s;s expertise, focus and strong capital base provide solid support for its clients&s; needs. The bank offers tailored products and solutions aided by the latest in technological innovations. To serve its relationships, Square 1 has offices coast to coast in Austin, Boston, DC, Denver, Durham, New York, San Diego, Santa Monica, Seattle, and Silicon Valley.
Contact Phone:
+18663550468
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
3/28/2014
IPO Valuation:
$490M
Ticker Symbol:
SQBK
IPO Price:
$18/share
Amount Raised:
$104M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
7/2011 | Avisena | Debt Financing | 2.5M |
8/2012 | Netsertive | Debt Financing | 2.5M |
6/2016 | NICO | Debt Financing | 8M |
7/2014 | EdgeWave | Debt Financing | 5M |
10/2007 | Magnite | Debt Financing | 1M |
6/2013 | Green Cloud Defense | Debt Financing | 3M |
6/2016 | Payzer | Debt Financing | 1.5M |
2/2014 | GTxcel | Debt Financing | 4M |
4/2015 | Sirrus, Inc. | Debt Financing | 5M |
8/2016 | ReVision Optics | Debt Financing | 10M |
9/2014 | Netsertive | Debt Financing | 7.5M |
8/2014 | Heat Biologics | Post-IPO Debt | 7.5M |
7/2015 | Emma | Venture Round | 5M |
9/2016 | Zavante Therapeutics | Debt Financing | 10M |
3/2017 | Surefire Local | Debt Financing | 1M |
12/2016 | OneCause (formerly BidPal) | Debt Financing | 2.5M |
10/2013 | NeoChord | Debt Financing | 3M |
8/2015 | Azalea Health | Debt Financing | 1.5M |
10/2007 | MicroSeismic | Debt Financing | 2M |
6/2015 | Sebacia | Debt Financing | 10M |
12/2006 | Aldagen | Debt Financing | 3M |
9/2011 | NuScriptRx | Debt Financing | 5M |
6/2016 | y prime | Debt Financing | 5M |
4/2013 | SteadyMed Therapeutics | Debt Financing | 3M |
1/2014 | NutraMed | Debt Financing | 12.5M |
1/2017 | Bardy Diagnostics | Series A | - |
7/2016 | Optoro | Debt Financing | 40M |
4/2015 | VisiQuate | Debt Financing | 50k |
11/2012 | Spruce Media | Debt Financing | 15M |
12/2015 | Schweiger Dermatology | Debt Financing | 8M |
8/2011 | Profit Point | Debt Financing | 2.5M |
6/2009 | Local Corporation | Post-IPO Debt | 10M |
4/2016 | Windsor Circle | Debt Financing | 2.5M |
9/2013 | OnDeck | Debt Financing | 130M |
3/2017 | Cogent Biosciences | Debt Financing | 15M |
5/2013 | Sellpoints | Debt Financing | 3M |
9/2013 | Nomis Solutions | Debt Financing | 5M |
6/2017 | My Health Direct | Debt Financing | 4M |
2/2015 | Distil Networks | Debt Financing | 3M |
4/2014 | CFN Enterprises | Post-IPO Debt | 3M |
9/2015 | Skillz | Debt Financing | 3M |
9/2017 | ViralGains | Series B | 13.5M |
12/2015 | Zavante Therapeutics | Venture Round | 10M |
6/2018 | Recursion Pharmaceuticals | Debt Financing | 20.5M |
11/2016 | Cidara Therapeutics | Post-IPO Debt | 20M |
3/2013 | Carolus Therapeutics | Debt Financing | 2.3M |
8/2016 | Revionics | Debt Financing | - |
12/2018 | ShopKeep | Debt Financing | - |
12/2016 | TVA Medical | Debt Financing | 7M |
2/2009 | Rally Software | Series D | 8M |
1/2017 | ScaleArc | Debt Financing | 7.5M |
5/2017 | CIC Partners | Debt Financing | 20M |
7/2016 | ReviewTrackers | Debt Financing | - |
11/2013 | Sittercity | Series C | 0 |
8/2007 | Red Condor | Debt Financing | 7.7M |
10/2011 | Ocunexus Therapeutics | Debt Financing | 6M |
1/2015 | Trevi Therapeutics | Debt Financing | 15M |
7/2012 | MapMyFitness | Venture Round | 3M |
10/2014 | InVisage Technologies | Debt Financing | - |
5/2014 | Evoke Pharma | Post-IPO Debt | 4.5M |
2/2013 | HNI Healthcare | Debt Financing | 2.5M |
11/2013 | Talari Networks | Debt Financing | 7.5M |
5/2012 | iScience Interventional | Debt Financing | 5M |
5/2015 | InDemand Interpreting | Debt Financing | 3M |
7/2013 | Foundation Radiology | Debt Financing | 6M |
12/2013 | Sittercity | Debt Financing | 0 |
6/2016 | Contactually | Debt Financing | 3M |
4/2014 | Conventus Orthopaedics | Debt Financing | 10M |
6/2015 | Maker Media | Series A | 5M |
6/2018 | Zurex Pharma | Series D | 9M |
11/2008 | Trust Digital | Series C | 0 |
5/2015 | Symbiomix Therapeutics | Series A | 41M |
6/2014 | Vascular Pathways | Debt Financing | 0 |
9/2014 | Trevena | Post-IPO Debt | 35M |
4/2014 | SpringCM | Venture Round | 18M |
7/2011 | Razorsight | Series B | 0 |
6/2016 | SpringCM | Equity | 17.5M |
9/2007 | MerchantCircle | Series B | 10M |
8/2017 | Bizible | Venture Round | 0 |
12/2008 | Smart Destinations | Debt Financing | 3M |
8/2011 | Local Corporation | Post-IPO Debt | 12M |
8/2015 | Target Data | Debt Financing | 1.5M |
12/2015 | Aratana Therapeutics | Post-IPO Debt | 40M |
6/2017 | Alert Logic | Debt Financing | 70M |
9/2016 | BAROnova | Debt Financing | 7.5M |
8/2014 | Tarsa Therapeutics | Debt Financing | 10M |
8/2016 | Panopto | Private Equity Round | 42.8M |
3/2017 | SparkPost | Debt Financing | 10.5M |
6/2013 | Tubular Labs | Debt Financing | 1M |
12/2011 | Zmags | Debt Financing | 7M |
10/2018 | CallRail | Debt Financing | 0 |
11/2016 | Montage | Debt Financing | 2M |
1/2015 | Obalon Therapeutics | Debt Financing | 10M |
8/2007 | ITM Software | Venture Round | 0 |
6/2011 | Lendio | Debt Financing | 2M |
1/2017 | Argonaut Manufacturing Services, Incorporated. | Debt Financing | 5M |
7/2008 | Perfect Market | Series A | 15.6M |
9/2014 | Varentec | Debt Financing | 4M |
1/2013 | Peerless Network | Debt Financing | 15M |
11/2006 | NewHope Bariatrics | Private Equity Round | 18.5M |
11/2016 | BioConsortia | Debt Financing | 4M |
9/2014 | Formation Data Systems | Series A | 24.2M |
9/2015 | Molio | Debt Financing | 1M |
8/2015 | DialogTech | Debt Financing | 10M |
11/2017 | AllyO | Series A | 0 |
12/2018 | ShopKeep | Series E | 0 |
9/2015 | AvidXchange | Venture Round | 225M |
2/2012 | ComQi | Venture Round | 0 |
10/2018 | Paro | Debt Financing | 0 |
1/2016 | PlayMaker CRM | Debt Financing | 3M |
2/2017 | Recursion Pharmaceuticals | Debt Financing | 4M |
4/2017 | Dizzion | Debt Financing | 4.3M |
11/2018 | ScienceLogic | Debt Financing | 0 |
12/2018 | ShopKeep | Debt Financing | - |
12/2018 | ShopKeep | Series E | 0 |
11/2018 | ScienceLogic | Debt Financing | 0 |
10/2018 | CallRail | Debt Financing | 0 |
10/2018 | Paro | Debt Financing | 0 |
6/2018 | Zurex Pharma | Series D | 0 |
6/2018 | Recursion Pharmaceuticals | Debt Financing | 0 |
11/2017 | AllyO | Series A | 0 |
9/2017 | ViralGains | Series B | 0 |
8/2017 | Bizible | Venture Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|